The question most people type is “does cinnamon lower blood sugar,” but the better question is “what did the cinnamon studies measure, in whom, and how big was the effect compared to the noise?”
Quick answer: Pooled trials in people with type 2 diabetes have reported modest average reductions in fasting glucose with cinnamon, while results for A1C are inconsistent and often not significant. The studies are small, short, and use different cinnamon species and doses, so the evidence is weaker than the marketing. Cinnamon is a spice with a plausible mechanism and a real coumarin safety question, not a substitute for any part of a treatment plan.
Why cinnamon keeps coming up
Cinnamon is cheap, familiar, and already in your pantry. That makes it attractive in a way that a chromium capsule never will be. Lab work going back decades found that compounds in cinnamon bark, especially certain polyphenols, can mimic some of insulin’s signaling in cells and slow the enzymes that break down carbohydrates in the gut. That gave researchers a reason to run human trials, and it gave supplement companies a reason to print “supports healthy blood sugar” on a bottle.
If you are newly diagnosed with prediabetes or type 2 diabetes, the appeal is obvious: a food, not a drug, that might nudge the numbers. The job here is to separate what cell studies suggest from what human trials have actually shown. If you are still getting oriented on the condition itself, the prediabetes guide and the insulin resistance guide are the place to start before worrying about any supplement.
What the research actually shows
The human evidence comes mostly from small randomized controlled trials, typically 30 to 140 participants, lasting 6 to 16 weeks, usually in people with type 2 diabetes. Several meta-analyses have pooled those trials. The pattern across them is fairly consistent:
- Fasting glucose: Meta-analyses have reported average reductions in the neighborhood of 10 to 25 mg/dL in participants taking cinnamon compared with placebo. The spread between individual trials is wide, and a few well-run trials found no effect at all.
- A1C: This is where it gets shaky. Some pooled analyses found a small average reduction, others found none that reached statistical significance. A1C reflects roughly three months of glucose, and many trials were too short to move it much either way.
- Lipids: Some analyses reported small average improvements in total cholesterol and triglycerides. Again, inconsistent across trials.
- Insulin sensitivity measures: A handful of small studies in people with prediabetes or metabolic syndrome reported improvements in fasting insulin or HOMA-IR; these are preliminary.
Any time you see “average reduction,” read it as a group statistic. An average of 15 mg/dL can hide participants who dropped 40 and participants who rose 10. Averages are not personal results, and nothing in these trials tells you which group you would be in.
What the research does not show matters just as much. There are no long-term outcome trials showing cinnamon reduces complications, cardiovascular events, or progression from prediabetes to diabetes. The trials are too short and too small for that. The Cochrane review on cinnamon for diabetes concluded that the evidence was insufficient to support its use, which is a sober counterweight to the headlines. You can scan the primary literature yourself with a PubMed search for cinnamon and type 2 diabetes trials.
Why the trials disagree
Three things explain most of the inconsistency, and all three matter when you read a label.
Species. Most trials used cassia cinnamon (the common grocery-store kind), which is high in coumarin. A few used Ceylon or a water extract. These are not interchangeable, and the Ceylon versus cassia comparison covers why.
Dose. Trials ranged from about 1 gram to 6 grams of ground cinnamon per day, or a few hundred milligrams of a concentrated extract. There was no clean dose-response relationship. The breakdown of study doses goes through what each trial actually used.
Baseline. Participants who started with higher fasting glucose tended to show larger average changes, which is partly regression to the mean and partly a real pattern. People with well-controlled glucose on medication showed little.
How to read a cinnamon supplement label
Most bottles will not tell you the species. If a label says only “cinnamon bark” or “Cinnamomum” without a species name, assume cassia. Look for:
- Species: Cinnamomum verum or zeylanicum is Ceylon; Cinnamomum cassia, aromaticum, or burmannii are cassia types.
- Form: Ground bark powder versus a water extract (sometimes standardized to polyphenols). Extracts remove most of the fat-soluble coumarin; powder does not.
- Amount per serving and whether the “serving” is one capsule or three.
- Third-party testing seals (USP, NSF, Informed Choice). These verify contents, not effectiveness.
The capsule versus kitchen cinnamon article goes further into whether a supplement is any different from the jar in your cabinet.
Safety, side effects, and medication interactions
Cinnamon is generally well tolerated at culinary amounts. At the gram-per-day doses used in trials, the main concern is coumarin. Cassia cinnamon contains enough coumarin that a few grams a day can exceed the tolerable daily intake set by European food-safety regulators, and coumarin has been linked to liver injury in sensitive people. If you have liver disease, drink alcohol regularly, or take medicines that are hard on the liver (including acetaminophen in high doses and statins), that is a conversation to have before adding daily cinnamon. The side-effects article covers this in detail.
Coumarin is also structurally related to anticoagulant drugs. Cinnamon itself is not a blood thinner, but anyone on warfarin or other anticoagulants should raise it with their prescriber rather than assume it is irrelevant.
Hypoglycemia warning: Combining any blood-sugar-active supplement with insulin, sulfonylureas, or other glucose-lowering medicines can push glucose too low. Symptoms include shakiness, sweating, confusion, and a fast heartbeat. Do not add a supplement to a medication plan without your prescriber’s knowledge.
Other reported effects include mouth irritation from cinnamon oil, allergic reactions in people sensitive to cinnamaldehyde, and digestive upset at high doses. The NCCIH summary on cinnamon is a reliable plain-language reference: NCCIH: Cinnamon.
One more note. Metabolic Clarity Labs sells a berberine product, and berberine has a larger trial base for glucose than cinnamon does. Hold MCL to the same standard you are applying here: ask what the studies measured, in whom, and for how long. The berberine guide lays that out, and the supplements for metabolic syndrome hub compares the evidence across all of the common options.
Questions to bring to your appointment
- Given my current medications, is there any interaction risk with daily cinnamon, especially around hypoglycemia?
- Do I have any liver concerns (elevated ALT or AST, fatty liver, regular alcohol use) that would make coumarin a bigger issue for me?
- If I try it, which number should we watch to see if it does anything for me: fasting glucose, post-meal readings, or A1C at my next draw?
- How long would a fair trial be before we decide it is or is not doing anything?
- Would you rather I focus on the dietary and activity changes first and leave supplements until later?
- Can we calculate my HOMA-IR from my next fasting insulin and glucose so we have a baseline?
About the author: Charles Kirkland is the founder of Metabolic Clarity Labs and author of The Journey Back. He is not a physician. This is general education, not a medically reviewed treatment plan.
Sources checked October 29, 2026. Discuss personal decisions with a qualified clinician or pharmacist. Do not start, stop, or change prescribed treatment based on this article.
Related reading: Supplements for Insulin Resistance.
Leave a Reply